Andreas Geier

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Chris Estes, Quentin M. Anstee, M. Arias et al. · Journal of Hepatology · 2018 · 2K citations · Full text

Medicine, Health Sciences, Epidemiologic Methods +16

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis

Hermann E. Wasmuth, Dagmar Kunz, Eray Yagmur et al. · Journal of Hepatology · 2004 · 544 citations

Medicine, Immunology, Internal Medicine +14

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Are There Better Guidelines for Allocation in Liver Transplantation?

Philipp Dutkowski, Christian E. Oberkofler, Ksenija Slankamenac et al. · Annals of Surgery · 2011 · 410 citations

Medicine, Surgery, Risk Assessment +16